company background image
ATRC

AtriCure NasdaqGM:ATRC Stock Report

Last Price

US$43.86

Market Cap

US$2.0b

7D

-4.6%

1Y

-37.6%

Updated

08 Dec, 2022

Data

Company Financials +
ATRC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

ATRC Stock Overview

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.

AtriCure, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AtriCure
Historical stock prices
Current Share PriceUS$43.86
52 Week HighUS$74.85
52 Week LowUS$32.51
Beta1.25
1 Month Change7.92%
3 Month Change-5.58%
1 Year Change-37.62%
3 Year Change42.50%
5 Year Change143.26%
Change since IPO211.51%

Recent News & Updates

Recent updates

Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?

Sep 06
Is Now An Opportune Moment To Examine AtriCure, Inc. (NASDAQ:ATRC)?

An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued

Aug 02
An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 29% Undervalued

Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Jun 08
Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?

Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?

May 08
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?

Is AtriCure, Inc. (NASDAQ:ATRC) Expensive For A Reason? A Look At Its Intrinsic Value

Apr 11
Is AtriCure, Inc. (NASDAQ:ATRC) Expensive For A Reason? A Look At Its Intrinsic Value

Is AtriCure (NASDAQ:ATRC) A Risky Investment?

Feb 18
Is AtriCure (NASDAQ:ATRC) A Risky Investment?

Why AtriCure, Inc. (NASDAQ:ATRC) Could Be Worth Watching

Jan 20
Why AtriCure, Inc. (NASDAQ:ATRC) Could Be Worth Watching

Robust Earnings May Not Tell The Whole Story For AtriCure (NASDAQ:ATRC)

Nov 11
Robust Earnings May Not Tell The Whole Story For AtriCure (NASDAQ:ATRC)

Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

Oct 21
Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

AtriCure (NASDAQ:ATRC) Has Debt But No Earnings; Should You Worry?

Jul 23
AtriCure (NASDAQ:ATRC) Has Debt But No Earnings; Should You Worry?

Here's Why We Think AtriCure, Inc.'s (NASDAQ:ATRC) CEO Compensation Looks Fair for the time being

May 14
Here's Why We Think AtriCure, Inc.'s (NASDAQ:ATRC) CEO Compensation Looks Fair for the time being

AtriCure (NASDAQ:ATRC) Has Debt But No Earnings; Should You Worry?

Apr 18
AtriCure (NASDAQ:ATRC) Has Debt But No Earnings; Should You Worry?

The AtriCure (NASDAQ:ATRC) Share Price Has Gained 290%, So Why Not Pay It Some Attention?

Feb 07
The AtriCure (NASDAQ:ATRC) Share Price Has Gained 290%, So Why Not Pay It Some Attention?

Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

Jan 17
Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

How Should Investors React To AtriCure's (NASDAQ:ATRC) CEO Pay?

Dec 27
How Should Investors React To AtriCure's (NASDAQ:ATRC) CEO Pay?

Shareholder Returns

ATRCUS Medical EquipmentUS Market
7D-4.6%-1.1%-2.8%
1Y-37.6%-20.9%-19.6%

Return vs Industry: ATRC underperformed the US Medical Equipment industry which returned -22.9% over the past year.

Return vs Market: ATRC underperformed the US Market which returned -21.2% over the past year.

Price Volatility

Is ATRC's price volatile compared to industry and market?
ATRC volatility
ATRC Average Weekly Movement7.7%
Medical Equipment Industry Average Movement8.9%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: ATRC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: ATRC's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000875Mike Carrelhttps://www.atricure.com

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes.

AtriCure, Inc. Fundamentals Summary

How do AtriCure's earnings and revenue compare to its market cap?
ATRC fundamental statistics
Market CapUS$2.04b
Earnings (TTM)-US$56.04m
Revenue (TTM)US$315.57m

6.5x

P/S Ratio

-36.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ATRC income statement (TTM)
RevenueUS$315.57m
Cost of RevenueUS$79.73m
Gross ProfitUS$235.84m
Other ExpensesUS$291.88m
Earnings-US$56.04m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.20
Gross Margin74.74%
Net Profit Margin-17.76%
Debt/Equity Ratio13.3%

How did ATRC perform over the long term?

See historical performance and comparison